References
- Poelaert D, Pereira P, Gardner R, Standaert B, Benninghoff B. A review of recommendations for rotavirus vaccination in Europe: arguments for change. Vaccine. 2018;36(17):2243–53. doi:10.1016/j.vaccine.2018.02.080. PMID:29576308.
- Ministero della Salute. Piano Nazionale Prevenzione Vaccinale: PNPV 2017–2019. In Gazzetta Ufficiale della Repubblica Italiana; 2017. . [accessed 2020 Jan 27]. http://www.trovanorme.salute.gov.it/norme/renderPdf.spring?seriegu=SG&datagu=18/02/2017&redaz=17A01195&artp=1&art=1&subart=1&subart1=10&vers=1&prog=001.
- Ministero della Salute. CIRCOLARE del Ministero della Salute n. 25146 Circolare recante prime indicazioni operative riguardanti il comma 1-quater, art. 1 del decreto-legge n. 73 del 7 giugno 2017, convertito con modificazioni dalla legge 31 luglio 2017, n. 119, recante “Disposizioni urgenti in materia di prevenzione vaccinale, di malattie infettive e di controversie relative alla somministrazione di farmaci” (17G00132) (GU Serie Generale n. 182 del 05-08-2017); 2017 [accessed 2020 Jan 27]. http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2017&codLeg=60284&parte=1%20&serie=null.
- Ministero della Salute. CIRCOLARE del Ministero della Salute n. 7903 Aspetti operativi per la piena e uniforme implementazione del nuovo PNPV 2017–2019 e del relativo Calendario Vaccinale; 2017 [accessed 2020 Jan 27]. http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2017&codLeg=58583&parte=1%20&serie=null.
- Costantino C, Restivo V, Tramuto F, Casuccio A, Vitale F. Universal rotavirus vaccination program in Sicily: reduction in health burden and cost despite low vaccination coverage. Hum Vaccin Immunother. 2018;14(9):2297–302. doi:10.1080/21645515.2018.1471306. PMID: 29757707.
- Mita V, Arigliani M, Zaratti L, Arigliani R, Franco E. Italian physicians’ opinions on rotavirus vaccine implementation. Pathogens. 2017;6(4):56. doi:10.3390/pathogens6040056. PMID:29099756.
- Marchetti F, Conforti G. Seconda indagine conoscitiva sull’opinione dei pediatri di famiglia italiani in merito alla vaccinazione contro i rotavirus. Societa Italiana di Igiene, Medicina Preventiva e Sanita Pubblica - 51st Congresso Nazionale. Riva del Garda (Italy); 2018. p. 225.
- Marchetti F, Vetter V, Conforti G, Esposito S, Bonanni P. Parents’ insights after pediatric hospitalization due to rotavirus gastroenteritis in Italy. Hum Vaccin Immunother. 2017;13(9):2155–59. doi:10.1080/21645515.2017.1336271. PMID:28609219.
- European Medicines Agency. Rotarix: EPAR - product information; 2019 [Date of last update 2019 Apr 05]. https://www.ema.europa.eu/en/documents/product-information/rotarix-epar-product-information_en.pdf.
- European Medicines Agency. RotaTeq: EPAR - product Information; 2018 [Date of last update 2018 Dec 07]. https://www.ema.europa.eu/en/documents/product-information/rotateq-epar-product-information_en.pdf.
- Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335(14):1022–28. doi:10.1056/NEJM199610033351404. PMID:8793926.
- Napolitano F, Ali Adou A, Vastola A, Angelillo IF. Rotavirus infection and vaccination: knowledge, beliefs, and behaviors among parents in Italy. Int J Environ Res Public Health. 2019;16(10):1807. doi:10.3390/ijerph16101807. PMID:31117274.
- Pellegrinelli L, Bubba L, Primache V, Chiaramonte I, Ruggeri FM, Fiore L, Binda S. Burden of pediatrics hospitalizations associated with Rotavirus gastroenteritis in Lombardy (Northern Italy) before immunization program. Ann Ist Super Sanita. 2015;51(4):346–51. doi:10.4415/ANN_15_04_16. PMID:26783223.
- Panatto D, Amicizia D, Ansaldi F, Marocco A, Marchetti F, Bamfi F, Giacchino R, Tacchella A, Del Buono S, Gasparini R. Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy). Vaccine. 2009;27(25–26):3450–53. doi:10.1016/j.vaccine.2009.01.054. PMID:19200850.
- European Medicines Agency. Bexsero: EPAR - product information; 2018 [Date of last update 2018 July 11]. https://www.ema.europa.eu/en/documents/product-information/bexsero-epar-product-information_en.pdf.
- Societa Italiena di Pediatria. Calendario per la Vita, 4° edizione 2019; 2019 [accessed 2020 Jan 27]. https://www.sip.it/wp-content/uploads/2019/07/Calendario-vaccinale-per-la-Vita-2019.pdf.
- O’Ryan M, Stoddard J, Toneatto D, Wassil J, Dull PM. A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program. Drugs. 2014;74(1):15–30. doi:10.1007/s40265-013-0155-7. PMID:24338083.
- Public Health England. The complete routine immunisation schedule from summer 2016. [born on or before 2017 July 31]; 2016 [accessed 2020 Jan 27]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/533829/9699_PHE_2016_Complete_Immunisation_Schedule_SUMMER16_A4_16.pdf.
- Screening & Immunisations Team ND. Childhood vaccination coverage statistics, England 2017–18, national statistics; 2018 [accessed 2020 Jan 27]. https://files.digital.nhs.uk/55/D9C4C2/child-vacc-stat-eng-2017-18-report.pdf.
- Office for National Statistics. Births in England and Wales: 2018; 2019 [accessed 2020 Feb 11]. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/bulletins/birthsummarytablesenglandandwales/2018.
- Pereira P, Benninghoff B, Moerman L. Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines. Hum Vaccin Immunother. 2020:1–12. doi:10.1080/21645515.2020.1739485.PMID: 32298219.
- Bryan P, Seabroke S, Wong J, Donegan K, Webb E, Goldsmith C, Vipond C, Feavers I. Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study. Lancet Child Adolesc Health. 2018;2(6):395–403. doi:10.1016/s2352-4642(18)30103-2. PMID: 30169281.
- Sadarangani M, Barlow S, Anthony M, Pollard AJ. Four component meningococcal capsular group B vaccine in preterm infants. J Pediatric Infect Dis Soc. 2017;6(3):309–10. doi:10.1093/jpids/pix013. PMID: 28369464.
- ASL Mantova. Il Manuale delle Vaccinazioni; 2015 [accessed 2020 Jan 27]. https://www.aslmn.net/docs_file/Manuale_delle_Vaccinazioni.pdf.
- Trotta F, Da Cas R, Bella A, Santuccio C, Salmaso S. Intussusception hospitalizations incidence in the pediatric population in Italy: a nationwide cross-sectional study. Ital J Pediatr. 2016;42:89. doi:10.1186/s13052-016-0298-8. PMID:27677340.
- Mattei A, Fiasca F, Mazzei M, Sbarbati M. Unparalleled patterns of intussusception and rotavirus gastroenteritis hospitalization rates among children younger than six years in Italy. Ann Ig. 2017;29:38–45. doi:10.7416/ai.2017.2130. PMID:28067936.
- Agenzia Italiana del Farmaco. Rapporto vaccini 2018; 2018 [accessed 2020 Jan 27]. https://www.aifa.gov.it/documents/20142/241056/Rapporto+Vaccini+2018.pdf/62975a0e-a836-da32-f7b9-1e39196374dd.
- Restivo V, Costantino C, Giorgianni G, Cuccia M, Tramuto F, Corsello G, Casuccio A, Vitale F. Case-control study on intestinal intussusception: implications for anti-rotavirus vaccination. Expert Rev Vaccines. 2018;17(12):1135–41. doi:10.1080/14760584.2018.1546122. PMID: 30407079.
- Daskalaki I, Spain CV, Long SS, Watson B. Implementation of rotavirus immunization in Philadelphia, Pennsylvania: high levels of vaccine ineligibility and off-label use. Pediatrics. 2008;122(1):e33–38. doi:10.1542/peds.2007-2464. PMID:18595974.
- Krishnarajah G, Davis EJ, Fan Y, Standaert BA, Buikema AR. Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States. Vaccine. 2012;30(24):3717–22. doi:10.1016/j.vaccine.2011.12.077. PMID:22214886.
- Krishnarajah G, Landsman-Blumberg P, Eynullayeva E. Rotavirus vaccination compliance and completion in a Medicaid infant population. Vaccine. 2015;33(3):479–86. doi:10.1016/j.vaccine.2014.06.059. PMID:24962753.
- Eisenberg DF, Gu T, Krishnarajah G. Adherence to rotavirus vaccination quality measures in a commercially insured population. Hum Vaccin Immunother. 2013;9(2):389–97. doi:10.4161/hv.22877. PMID:23291933.
- Luna-Casas G, Juliao P, Carreno-Manjarrez R, Castaneda-Prado A, Cervantes-Apolinar MY, Navarro-Rodriguez R, Sanchez-Gonzalez G, Cortes-Alcala R, DeAntonio R. Vaccine coverage and compliance in Mexico with the two-dose and three-dose rotavirus vaccines. Hum Vaccin Immunother. 2019;15(6):1251–59. doi:10.1080/21645515.2018.1540827. PMID:30380975.
- Sabbe M, Berger N, Blommaert A, Ogunjimi B, Grammens T, Callens M, Van Herck K, Beutels P, Van Damme P, Bilcke J. Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014. Euro Surveill. 2016;21(27). doi:10.2807/1560-7917.ES.2016.21.27.30273. PMID: 27418466.
- Aquilani S, Dari S, Fiasca F. Assessing rotavirus vaccination coverage and compliance after two years of local experience in Italy. Ann Ig. 2020;32(4):433–35. doi:10.7416/ai.2020.2367.PMID: 32744302.